樂普生物科技股份有限公司 LEPU BIOPHARMA CO., LTD.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, 樂普生物科技股份有限公司 LEPU BIOPHARMA CO., LTD. disclosed greenhouse gas emissions of 6.1K metric tons (2023). By scope: Scope 1: 1.7K metric tons (2023); Scope 2: 4.4K metric tons (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
6.1K metric tons (2023)
2023
💧
Water Usage
47.8K metric tons (2023)
2023
♻️
Waste
27.07 metric tons (2023)
2023
⚙️
Energy Use
14.5K MWh (2023)
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).1.7K metric tons (2023)
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.4.4K metric tons (2023)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Climate ChangeEnvironmental ProtectionResource ManagementEmployee Well-beingHealth and SafetySupply Chain ManagementProduct Quality and SafetyResponsible MarketingAnti-corruptionCommunity InvestmentIntellectual Property Rights

⚠️ Challenges & Risks +

  • Treatment of waste gas from experiments.
  • Potential impacts of environmental and climate change risks on company operations.
  • Intense competition and rapid technological change in the biopharmaceutical industry.
  • Regulatory approval processes for drug candidates.
  • Maintaining sufficient cash and cash equivalents to meet operating capital requirements.

📋 Report Information

Reporting Period: 2023
Frameworks: ESG Reporting Guide in the Main Board Listing Rules (HKEX)